ELTP - Elite Pharmaceuticals GAAP EPS of $0.00 revenue of $8.97M February, 15 2022 12:52 AM Elite Pharmaceuticals Inc. Elite Pharmaceuticals press release (OTCQB:ELTP): FQ3 GAAP EPS of $0.00. Revenue of $8.97M (+48.3% Y/Y). 10Q For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $8.97M